Financials

v3.26.1
Statements of Assets and Liabilities - USD ($)
Mar. 31, 2026
Dec. 31, 2025
ASSETS    
Total investments at fair value $ 13,906,408 $ 14,261,455
Cash and cash equivalents 212,531 241,832
Restricted cash 5,000 5,000
Due from portfolio companies 34,397 34,397
Interest receivable, net of allowance for bad debt of $0 and $0, respectively 196,591 148,721
Prepaid expenses 34,716 67,194
Total assets 14,389,643 14,758,599
LIABILITIES    
Accrued management fees 173,533 135,373
Accounts payable 276,428 130,390
Due to affiliates [1] 259,500 194,625
Taxes payable 570 456
Accrued expenses and other liabilities 49,090 34,754
Total liabilities 759,121 495,598
Net assets 13,630,522 14,263,001
NET ASSETS    
Common Stock, par value $0.001 per share (250,000,000 shares authorized; 120,486,061 shares issued and outstanding at March 31, 2026 and December 31, 2025) 120,486 120,486
Paid-in capital 64,868,884 64,868,884
Accumulated deficit (51,358,848) (50,726,369)
Total net assets $ 13,630,522 $ 14,263,001
Net asset value per share (in Dollars per share) $ 0.113 $ 0.118
Control Investments    
ASSETS    
Total investments at fair value $ 12,077,237 $ 12,188,395
Non-control/non-affiliate investments    
ASSETS    
Total investments at fair value $ 1,829,171 $ 2,073,060
[1] Amounts under Due to Affiliates are for accrued amounts payable to the Company’s investment advisor, House Hanover, LLC, for the reimbursement of administration fees that it incurs on the Company’s behalf (Note 6).

Source

v3.26.1
Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
INVESTMENT INCOME    
Interest income from non-control/non-affiliate investments $ 3,329 $ 1,973
Interest income from control investments 66,584 66,584
Other income 4 17
Total investment income 73,405 72,062
OPERATING EXPENSES    
Management fees 38,160 48,760
Administration fees 89,875 107,024
Audit fees 63,000 98,800
Legal fees 28,676 41,888
Valuation fees 22,500 22,500
Other professional fees 7,875
Directors’ fees 38,625 43,125
Insurance expense 32,476 32,476
Other general and administrative expenses 29,536 25,779
Total operating expenses 350,723 420,352
Net investment loss before tax (277,318) (348,290)
Income tax expense 114 114
Net investment loss after taxes (277,432) (348,404)
Net change in unrealized loss on:    
Net change in unrealized loss on investments (355,047) (1,701,765)
Net decrease in net assets resulting from operations [1] $ (632,479) $ (2,050,169)
Net investment loss per share    
Basic (in Dollars per share) $ (0.002) $ (0.003)
Diluted (in Dollars per share) (0.002) (0.003)
Net decrease in net assets resulting from operations per share    
Basic (in Dollars per share) [1] (0.005) (0.017)
Diluted (in Dollars per share) [1] $ (0.005) $ (0.017)
Weighted average shares of common stock outstanding    
Basic (in Shares) [1],[2] 120,486,061 120,486,061
Diluted (in Shares) [1] 120,486,061 120,486,061
Non-control/non-affiliate investments    
INVESTMENT INCOME    
Other income $ 3,488 $ 3,488
Net change in unrealized loss on:    
Net change in unrealized loss on investments (243,889) (421,875)
Control investments    
Net change in unrealized loss on:    
Net change in unrealized loss on investments $ (111,158) $ (1,279,890)
[1] Per share data based on weighted average shares outstanding.
[2] Financial highlights are based on weighted average shares outstanding.

Source

v3.26.1
Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net decrease in net assets resulting from operations [1] $ (632,479) $ (2,050,169)
Adjustments to reconcile net decrease in net assets resulting from operations to net cash used in operating activities:    
Net change in unrealized loss on investments 355,047 1,701,765
Changes in operating assets and liabilities:    
Due from portfolio companies (525)
Interest receivable (47,870) (493)
Prepaid expenses 32,478 32,476
Accrued management fees 38,160 48,760
Accounts payable 146,038 62,535
Due to affiliates 64,875 64,875
Taxes payable 114 114
Accrued expenses and other liabilities 14,336 39,637
Net cash used in operating activities (29,301) (101,025)
Net decrease in cash, cash equivalents and restricted cash (29,301) (101,025)
Cash, cash equivalents and restricted cash at beginning of period 246,832 1,295,864
Cash, cash equivalents and restricted cash at end of period $ 217,531 $ 1,194,839
[1] Per share data based on weighted average shares outstanding.

Source